Cantor Fitzgerald Predicts Lower Earnings for Ryan Specialty

Key Points

• Cantor Fitzgerald has revised its FY2025 earnings per share estimate for Ryan Specialty to $2.06, slightly down from the previous estimate of $2.07, maintaining a "Hold" rating on the stock.
• The consensus estimate for Ryan Specialty's earnings is higher at $2.29 per share, highlighting a significant difference in analyst expectations for the upcoming year.
• Insider activity includes Chairman Patrick G. Ryan purchasing 276,634 shares at $51.84 each, resulting in a significant increase in his ownership stake in the company.

Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) - Analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Ryan Specialty in a note issued to investors on Thursday, October 9th. Cantor Fitzgerald analyst R. Tunis now anticipates that the company will earn $2.06 per share for the year, down from their prior estimate of $2.07. Cantor Fitzgerald currently has a "Hold" rating on the stock. The consensus estimate for Ryan Specialty's current full-year earnings is $2.29 per share. Cantor Fitzgerald also issued estimates for Ryan Specialty's FY2026 earnings at $2.38 EPS.

RYAN has been the subject of a number of other reports. Weiss Ratings reiterated a "hold (c-)" rating on shares of Ryan Specialty in a report on Wednesday. Barclays restated an "overweight" rating and issued a $70.00 price objective on shares of Ryan Specialty in a report on Wednesday. Wolfe Research upgraded shares of Ryan Specialty to a "strong-buy" rating in a report on Tuesday, September 16th. UBS Group lowered their price objective on shares of Ryan Specialty from $80.00 to $75.00 and set a "buy" rating for the company in a report on Wednesday. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Ryan Specialty from $64.00 to $63.00 and set an "underweight" rating for the company in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $71.08.

Ryan Specialty Stock Performance

Ryan Specialty stock opened at $55.56 on Friday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.88. The firm has a 50-day moving average of $56.33 and a 200-day moving average of $64.14. The firm has a market cap of $14.65 billion, a P/E ratio of 158.75, a P/E/G ratio of 1.63 and a beta of 0.63. Ryan Specialty has a 1-year low of $50.08 and a 1-year high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting analysts' consensus estimates of $0.66. The company had revenue of $855.17 million during the quarter, compared to analyst estimates of $837.52 million. Ryan Specialty had a net margin of 6.81% and a return on equity of 48.70%. Ryan Specialty's revenue for the quarter was up 23.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.58 earnings per share.

Hedge Funds Weigh In On Ryan Specialty

Large investors have recently made changes to their positions in the business. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Ryan Specialty by 281.6% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock valued at $25,000 after purchasing an additional 245 shares during the last quarter. SVB Wealth LLC purchased a new position in shares of Ryan Specialty during the first quarter valued at approximately $26,000. WPG Advisers LLC purchased a new position in shares of Ryan Specialty during the first quarter valued at approximately $32,000. Golden State Wealth Management LLC lifted its holdings in shares of Ryan Specialty by 10,975.0% during the second quarter. Golden State Wealth Management LLC now owns 443 shares of the company's stock valued at $30,000 after purchasing an additional 439 shares during the last quarter. Finally, Central Pacific Bank Trust Division purchased a new position in shares of Ryan Specialty during the second quarter valued at approximately $31,000. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Ryan Specialty news, Chairman Patrick G. Ryan bought 276,634 shares of the stock in a transaction dated Friday, September 12th. The stock was purchased at an average cost of $51.84 per share, for a total transaction of $14,340,706.56. Following the completion of the acquisition, the chairman owned 13,699,959 shares of the company's stock, valued at approximately $710,205,874.56. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 52.21% of the company's stock.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 26th. Stockholders of record on Tuesday, August 12th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Tuesday, August 12th. Ryan Specialty's dividend payout ratio (DPR) is presently 137.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.